The first-in-class muscarinic agonist Cobenfy, formerly known as KarXT, was just approved by the FDA to treat schizophrenia in adults. Are you ready to discuss it with patients and caregivers?
Psychiatric Times Editors
Advertisement
Articles by Psychiatric Times Editors
Enter your email to see the results of our polls on social media usage amongst mental health clinicians!
How comfortable do you feel in your knowledge of this type of treatment?
Tell us more about how you use social media as a mental health clinician!
Tell us more about how you use social media as a mental health clinician!
Tell us more about how you use social media!
Here are highlights from the week in Psychiatric Times.
Answer a quick question on psychedelics!
Answer a quick question about psychedelics!
Answer a quick question on psychedelics!
Answer a quick question on psychedelics!
Answer a quick question on psychedelics!
Answer a quick question on psychedelics!
Write to us now for a chance to be featured in our upcoming Special Report on Addiction.
We asked some of the presenters and attendees of the upcoming 2024 APA Annual Meeting what they were excited about. Here's what they said.
Are you coming to the 2024 APA Annual Meeting? We'll see you there!
Let us know if we'll see you there!
Have you checked out the latest Translating Research Into Practice column? Let us know!
What are your top 3 ethics issues? Take our survey!
We're looking for articles with an emphasis on clinical care for marginalized populations...
Biogen announced its decision to discontinue all development and sales of aducanumab (Aduhelm) for Alzheimer disease. Is this surprising?
Tell us what you're thankful for!
Get ready for our upcoming virtual, interactive conference with some highlights from 2022.
Today is World Alzheimer's Day!
September 15 to October 15 is Hispanic Heritage Month. To celebrate, here’s a look at some recent coverage in Psychiatric Times® on how clinicians can improve psychiatric care for Latinx patients.
Today is World Suicide Prevention Day. Take a look at our latest content on suicide.
In honor of Labor Day 2023, here are some recent expert discussions on burnout prevention as seen in Psychiatric Times®.
As we enter fall, we want to know what you're excited about in psychiatry!
Advertisement
Advertisement
Advertisement
Trending on Psychiatric Times
1
Olanzapine LAI (Weltruza) Receives FDA Approval for Schizophrenia
2
The New, Impending Adult ADHD Guidelines
3
Two New MDD Approvals: 5-HT1A Agonism and Adjunctive Atypical Antipsychotics
4
Moving Away From Treatment-Resistant Depression and Toward Difficult-to-Treat Depression
5